​

Dr. Reddy's Laboratories (RDY) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

RDY Stock Rating

Dr. Reddy's Laboratories stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (60.00%), 3 Hold (30.00%), 1 Sell (10.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 1 3 6 Strong Sell Sell Hold Buy Strong Buy

RDY Price Target Upside V Benchmarks

TypeNameUpside
StockDr. Reddy's Laboratories-
SectorHealthcare Stocks 24.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks29.65%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$16.17$16.17$16.17
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-121-4
May, 25-121-4
Apr, 25-121-4
Mar, 251121-5
Feb, 251121-5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 19, 2024NomuraNeutraldowngrade
Jul 30, 2024BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $70 $140 $210 $280 $350 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$103.94$142.08$271.47$334.02----
Avg Forecast$151.87$171.79$47.23$64.18$67.09$69.16$61.39$68.09
High Forecast$168.72$190.85$49.57$64.67$68.77$74.16$64.43$71.46
Low Forecast$133.75$151.29$44.88$64.02$63.73$64.99$58.33$64.70
Surprise %-31.56%-17.29%474.78%420.44%----

Revenue Forecast

$150B $220B $290B $360B $430B $500B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$189.72B$214.39B$245.88B$279.16B----
Avg Forecast$190.37B$212.60B$242.04B$277.32B$320.55B$348.92B$346.78B$446.72B
High Forecast$206.62B$230.75B$251.26B$287.88B$324.86B$364.98B$359.99B$463.74B
Low Forecast$172.89B$193.08B$232.77B$276.49B$315.38B$338.21B$333.50B$429.61B
Surprise %-0.34%0.84%1.59%0.67%----

Net Income Forecast

$0 $400B $800B $1T $2T $2T Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28
Reported$17.24B$23.57B$45.07B$55.68B----
Avg Forecast$25.32B$28.64B$39.37B$1.65T$55.92B$57.65B$51.17B$56.75B
High Forecast$28.13B$31.82B$41.32B$1.98T$57.32B$61.81B$53.70B$59.56B
Low Forecast$22.30B$25.22B$37.41B$1.32T$53.12B$54.17B$48.62B$53.93B
Surprise %-31.91%-17.71%14.47%-96.62%----

RDY Forecast FAQ

Is Dr. Reddy's Laboratories stock a buy?

Dr. Reddy's Laboratories stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Dr. Reddy's Laboratories is a favorable investment for most analysts.

What is Dr. Reddy's Laboratories's price target?

Dr. Reddy's Laboratories's price target, set by 10 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $16.17.

How does Dr. Reddy's Laboratories stock forecast compare to its benchmarks?

Dr. Reddy's Laboratories's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the specialty & generic drug manufacturers stocks industry (29.65%).

What is the breakdown of analyst ratings for Dr. Reddy's Laboratories over the past three months?

  • June 2025: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 25.00% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 25.00% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 25.00% Sell, 0% Strong Sell.

What is Dr. Reddy's Laboratories’s EPS forecast?

Dr. Reddy's Laboratories's average annual EPS forecast for its fiscal year ending in March 2025 is $67.09, marking a -79.91% decrease from the reported $334.02 in 2024. Estimates for the following years are $69.16 in 2026, $61.39 in 2027, and $68.09 in 2028.

What is Dr. Reddy's Laboratories’s revenue forecast?

Dr. Reddy's Laboratories's average annual revenue forecast for its fiscal year ending in March 2025 is $320.55B, reflecting a 14.83% increase from the reported $279.16B in 2024. The forecast for 2026 is $348.92B, followed by $346.78B for 2027, and $446.72B for 2028.

What is Dr. Reddy's Laboratories’s net income forecast?

Dr. Reddy's Laboratories's net income forecast for the fiscal year ending in March 2025 stands at $55.92B, representing an 0.42% increase from the reported $55.68B in 2024. Projections indicate $57.65B in 2026, $51.17B in 2027, and $56.75B in 2028.